ATE181503T1 - Verwendung von idazoxan und derivaten zur herstellung eines arzneimittels zur behandlung von parkinsonismus und seiner evolution - Google Patents
Verwendung von idazoxan und derivaten zur herstellung eines arzneimittels zur behandlung von parkinsonismus und seiner evolutionInfo
- Publication number
- ATE181503T1 ATE181503T1 AT94901988T AT94901988T ATE181503T1 AT E181503 T1 ATE181503 T1 AT E181503T1 AT 94901988 T AT94901988 T AT 94901988T AT 94901988 T AT94901988 T AT 94901988T AT E181503 T1 ATE181503 T1 AT E181503T1
- Authority
- AT
- Austria
- Prior art keywords
- idazoxan
- parkinsonism
- evolution
- derivatives
- treatment
- Prior art date
Links
- 208000027089 Parkinsonian disease Diseases 0.000 title 1
- 206010034010 Parkinsonism Diseases 0.000 title 1
- HPMRFMKYPGXPEP-UHFFFAOYSA-N idazoxan Chemical compound N1CCN=C1C1OC2=CC=CC=C2OC1 HPMRFMKYPGXPEP-UHFFFAOYSA-N 0.000 title 1
- 229950001476 idazoxan Drugs 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9214694A FR2698789B1 (fr) | 1992-12-07 | 1992-12-07 | Utilisation de l'idazoxan et ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson et de son évolution. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE181503T1 true ATE181503T1 (de) | 1999-07-15 |
Family
ID=9436284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94901988T ATE181503T1 (de) | 1992-12-07 | 1993-12-06 | Verwendung von idazoxan und derivaten zur herstellung eines arzneimittels zur behandlung von parkinsonismus und seiner evolution |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0671915B1 (de) |
| JP (1) | JPH08504203A (de) |
| AT (1) | ATE181503T1 (de) |
| AU (1) | AU687023B2 (de) |
| CA (1) | CA2151039A1 (de) |
| DE (1) | DE69325462D1 (de) |
| FR (1) | FR2698789B1 (de) |
| NZ (1) | NZ258591A (de) |
| WO (1) | WO1994013285A1 (de) |
| ZA (1) | ZA939153B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6281207B1 (en) * | 1999-09-15 | 2001-08-28 | Reed Richter | Treatment of movement disorders by administration of mirtazapine |
| FR2814368B1 (fr) * | 2000-09-26 | 2004-05-07 | Pf Medicament | Preparation pharmaceutique a base d'oxans |
| US8188126B2 (en) | 2002-05-16 | 2012-05-29 | Pierre Fabre Medicament | Imidazolic compounds and use thereof as alpha-2 adrenergic receptors |
| US8476307B2 (en) | 2003-10-28 | 2013-07-02 | Pierre Fabre Medicament | Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof |
| US7595335B2 (en) | 2003-10-28 | 2009-09-29 | Pierre Fabre Medicament | Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof |
| FR2861299B1 (fr) | 2003-10-28 | 2006-01-27 | Pf Medicament | Compositions pharmaceutiques a base de derives d'idasoxan sous formes polymorphes |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH16249A (en) * | 1980-02-04 | 1983-08-16 | Reckitt & Colmann Prod Ltd | Imidazoline derivatives,its pharmaceutical composition and method of use |
| NZ199469A (en) * | 1981-01-30 | 1984-03-16 | Reckitt & Colmann Prod Ltd | Benzodioxanyl-2-imidazoline derivatives and pharmaceutical compositions |
| NZ203680A (en) * | 1982-04-17 | 1985-08-16 | Reckitt & Colmann Prod Ltd | Imidazolines and pharmaceutical compositions |
| FR2669030B1 (fr) * | 1990-11-14 | 1992-12-31 | Adir | Nouveaux derives d'imidazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
-
1992
- 1992-12-07 FR FR9214694A patent/FR2698789B1/fr not_active Expired - Fee Related
-
1993
- 1993-12-06 CA CA002151039A patent/CA2151039A1/fr not_active Abandoned
- 1993-12-06 WO PCT/FR1993/001196 patent/WO1994013285A1/fr not_active Ceased
- 1993-12-06 AT AT94901988T patent/ATE181503T1/de not_active IP Right Cessation
- 1993-12-06 DE DE69325462T patent/DE69325462D1/de not_active Expired - Lifetime
- 1993-12-06 NZ NZ258591A patent/NZ258591A/en unknown
- 1993-12-06 JP JP6513855A patent/JPH08504203A/ja active Pending
- 1993-12-06 EP EP94901988A patent/EP0671915B1/de not_active Expired - Lifetime
- 1993-12-06 AU AU56530/94A patent/AU687023B2/en not_active Ceased
- 1993-12-07 ZA ZA939153A patent/ZA939153B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU5653094A (en) | 1994-07-04 |
| NZ258591A (en) | 1997-06-24 |
| WO1994013285A1 (fr) | 1994-06-23 |
| DE69325462D1 (de) | 1999-07-29 |
| JPH08504203A (ja) | 1996-05-07 |
| EP0671915B1 (de) | 1999-06-23 |
| FR2698789B1 (fr) | 1995-03-03 |
| FR2698789A1 (fr) | 1994-06-10 |
| EP0671915A1 (de) | 1995-09-20 |
| ZA939153B (en) | 1994-08-05 |
| AU687023B2 (en) | 1998-02-19 |
| CA2151039A1 (fr) | 1994-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE73331T1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
| DE69903750D1 (de) | Verwendung von langkettigen n-alkyl derivaten von deoxynojirimycin zur herstellung eines medikaments zur behandlung von mit glykolipiden akkumulation zusammenhängenden krankheiten | |
| NO170280C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfamatderivater | |
| DE3876877D1 (de) | Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus. | |
| PT82361A (fr) | Procede de preparation de derives benzonaphtaleniques et leur application dans le domaines pharmaceutique et cosmetique | |
| DE69201948D1 (de) | Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b. | |
| ATE268752T1 (de) | Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung | |
| ATE206914T1 (de) | Verwendung von ursolsäure zur herstellung eines arzneimittels zur unterdrückung von metastasen | |
| DE3888340D1 (de) | Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit. | |
| EP0369263A3 (de) | Präparate zur topischen Behandlung von Hautkrankheiten | |
| DE68908145D1 (de) | Verwendung von l-carnitinderivaten zur herstellung eines arzneimittels zur therapeutischen behandlung von peripheren neuropathien. | |
| ATE161725T1 (de) | Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina | |
| ATE135573T1 (de) | Verwendung von indazol-methoxyalkansäure zur herstellung eines arzneimittels zur behandlung von autoimmunkrankheiten | |
| ATE181503T1 (de) | Verwendung von idazoxan und derivaten zur herstellung eines arzneimittels zur behandlung von parkinsonismus und seiner evolution | |
| ATE169635T1 (de) | Therapeutische verbindungen für die behandlung von krankheiten, die mit einem glutathion-defizit assoziiert sind, herstellungsprozess und diese enthaltene pharmazeutische zusammensetzungen | |
| DE69518706D1 (de) | Verwendung von Diphenylethanderivaten zur Herstellung eines Arzneimittels zur Behandlung von Glaukom | |
| ATE38982T1 (de) | Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel. | |
| SE9702716D0 (sv) | Substituted phenylazacycloalkanes in the treatment of cognitive disorders | |
| ATE110568T1 (de) | Pharmazeutisches präparat zur behandlung des katarakts. | |
| DE69708084D1 (de) | Verwendung von pyridyl- und pyrimidyl-piperazinen zur herstellung eines medikaments zur behandlung von rauschgiftsbedingten beschwerden | |
| ATE192650T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
| DE69906728D1 (de) | Verwendung von 4-piperidinmethanolderivaten zur behandlung von neuralentwicklungsstörungen | |
| DE60005525D1 (de) | 2-aminotetraline zur behandlung von glaukom | |
| ATE212842T1 (de) | Quinoxalin-derivate zur behandlung von tinnitus | |
| ATE173921T1 (de) | Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |